Prioritering van borstkankerzorg tijdens coronacrisis

Zorg
20-07-2020
Yasmin A. Civil, T.P. (Ted) van Iersel, C. Willemien Menke-van der Houven van Oordt, Ellis Barbé en Susanne van der Velde

Om de zorgcapaciteit voor covid-19-patiënten te vergroten, is de reguliere zorg in de afgelopen maanden waar mogelijk uitgesteld. Zo ook de zorg voor borstkankerpatiënten. De beschikbaarheid van operatiekamers en zorgpersoneel nam (tijdelijk) af. Het ziekenhuisbezoek werd beperkt om de kans op besmetting te minimaliseren.

Prioritising breast cancer care during the corona crisis

Over the past few months, regular care has been postponed where possible in order to increase the healthcare capacity for COVID-19 patients. The pressure imposed on the healthcare system by the new coronavirus has led to the need for the prioritising of breast cancer care. Several professional scientific and medical organisations have published proposals to prioritise oncological care. Due to the poor prognosis, care for patients with progressive disease during neoadjuvant systemic therapy and a triple negative, may not be postponed. In certain groups of patients, including those with ductal carcinoma in situ or an endocrine sensitive tumour, treatment may be postponed or modified, although with certain reservations. At the initiative of the Nationaal Borstkanker Overleg Nederland, prospective data are currently being collected in order to gain more insight into the impact of COVID-19 on breast cancer care.

Conflict of interest and financial support: no conflicts of interest have been reported.